Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 studyAlexandre Bazinet, Farhad Ravandi, Nicholas J. Short et al.|The Lancet Haematology|2024Cited by 25